Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.3 USD | +0.96% | +3.45% | -49.80% |
30/05 | Baird Starts agilon health With Neutral Rating, $6 Price Target | MT |
24/05 | Truist Lifts Price Target on agilon health to $6.50 From $6.40, Maintains Hold Rating | MT |
Evolution of the average Target Price on agilon health, inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering agilon health, inc.
Baird | |
Truist Securities | |
Deutsche Bank Securities | |
Citigroup | |
Barclays | |
RBC Capital Markets | |
TD Cowen | |
Wolfe Research | |
JPMorgan Chase | |
Goldman Sachs | |
JMP Securities | |
Benchmark Company | |
Wells Fargo Securities | |
Evercore ISI | |
Stifel Nicolaus | |
Guggenheim | |
SVB Securities LLC | |
BTIG | |
SVB Leerink | |
Jefferies & Co. | |
Cowen | |
William Blair & Co. | |
BofA Securities | |
J.P. Morgan Chase |
EPS Revisions
- Stock Market
- Equities
- AGL Stock
- Consensus agilon health, inc.